...
【24h】

Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.

机译:最初通过乳腺MRI识别的高危病变的频率,升级率和特征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The purpose of this article is to determine the frequency, outcomes, and imaging features of high-risk lesions initially detected by breast MRI, including atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ, and radial scar. MATERIALS AND METHODS: A retrospective review of our MRI pathology database was performed to identify all lesions initially detected with MRI (January 2003 through May 2007) that underwent imaging-guided needle biopsy yielding high-risk histopathologic abnormalities. Patient age, clinical indication, MRI BI-RADS lesion features, biopsy method, and histopathologic diagnosis were recorded. The frequencies of high-risk findings at needle biopsy and rates of upgrade to malignancy at surgical excision were compared across lesion imaging features with Fisher's exact test. RESULTS: Four hundred eighty-two MRI-detected suspicious lesions underwent needle biopsy. High-risk histopathologic abnormalities were present in 61 (12.7%) of 482 lesions: 51 (10.6%) atypical ductal hyperplasias, six (1.2%) atypical lobular hyperplasias, three (0.6%) lobular carcinomas in situ, and one (0.2%) radial scar. Correlation between the lesion site and pathology at surgical excision was confirmed for 39 of 61 lesions. Twelve (30.8%) of those 39 lesions were upgraded to malignancy (11 atypical ductal hyperplasias and one atypical lobular hyperplasia); five (41.7%) of the 12 malignancies were invasive cancer, and seven (58.3%) were ductal carcinomas in situ. No significant lesion features predictive of subsequent upgrade to malignancy were discovered. CONCLUSION: There are no specific imaging features that predict upgrade for high-risk lesions when detected with MRI. Therefore, surgical excision is recommended because upgrade to invasive carcinoma or ductal carcinoma in situ can occur in up to 31% of cases, regardless of biopsy technique.
机译:目的:本文的目的是确定最初通过乳腺MRI检查发现的高危病变的频率,结果和影像学特征,包括非典型导管增生,非典型小叶增生,原位小叶癌和radial骨瘢痕。材料与方法:对我们的MRI病理数据库进行了回顾性研究,以鉴定最初通过MRI(2003年1月至2007年5月)检测到的所有病变,这些病变均经过了影像学指导的穿刺活检,从而产生了高危的组织病理学异常。记录患者年龄,临床指征,MRI BI-RADS病变特征,活检方法和组织病理学诊断。使用Fisher精确检验比较了病变影像学特征在穿刺活检中高风险发现的频率和在手术切除时恶性升级的频率。结果:482例MRI检测到的可疑病变接受了穿刺活检。高风险的组织病理学异常存在于482个病变中的61个(12.7%)中:51个(10.6%)非典型性导管增生,六个(1.2%)非典型性小叶增生,三个(0.6%)原位小叶癌和一个(0.2%) )放射状疤痕。证实了61个病变中有39个病变在手术切除时病变部位与病理之间的相关性。在这39个病变中,有12个(30.8%)升级为恶性肿瘤(11个非典型导管增生和1个非典型小叶增生)。 12例恶性肿瘤中有5例(41.7%)是浸润性癌,7例(58.3%)是原位导管癌。未发现可预测随后恶性肿瘤升级的明显病变特征。结论:没有特殊的影像学特征可以预测在MRI检查时高危病变的升级。因此,建议手术切除,因为无论活检技术如何,在多达31%的病例中均可发生浸润性癌或导管癌的升级。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号